Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Cumberland Pharmaceuticals Inc. (CPIX)

BGM Group Ltd. and Cumberland Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. and Cumberland Pharmaceuticals Inc. are of similar size ($114.7M and $113.0M). Cumberland Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 144×. BGM Group Ltd. has the higher net margin (1.96% vs −26.2%) and the higher return on invested capital (0.00% vs −34.2%). Across the 15 metrics below, BGM Group Ltd. leads on 8 and Cumberland Pharmaceuticals Inc. on 7.

Valuation

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
P/E 144.17 n/m 19.25
P/S n/m 2.58 2.11
P/B n/m 6.29 1.78
Price to free cash flow n/m 186.79 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales (0.09) 2.73 2.73
Earnings yield 0.69% (9.89%) (4.38%)
Free cash flow yield 0.00% 0.54% 0.00%

Profitability

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 82.80% 53.94%
Operating margin 0.00% (17.39%) 0.00%
Net margin 1.96% (26.17%) 0.00%
Free cash flow margin 0.00% 1.38% 0.00%
Return on equity 0.00% (48.76%) (0.40%)
Return on assets 0.00% (16.70%) (3.32%)
Return on invested capital 0.00% (34.23%) 0.00%

Growth

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 31.98% 10.01%
EPS growth (last fiscal year) 10.00% 58.70% 49.06%
Revenue growth, 5-year CAGR (5.39%) 3.52% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 1.25 0.96 2.31
Net debt to EBITDA 0.97 (4.58) 0.97

Dividend

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.57%
Payout ratio — — 0.27

Size

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Market cap 114.71m 112.97m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack